Breast cancer is a heterogeneous disease with different subtypes that are based upon the expression level of estrogen receptor (ER), progesterone receptor (PR), and HER-2/neu receptor (HER-2) [1]. This evidence concerns the gene ERBB2 and breast carcinoma.